Hearing loss in children in Østfold county 2000-09

Siri Nelson1, Ronny Andersen2, Sven-Harald Anderssen3

  • 1Barneavdelingen Sykehuset Østfold Fredrikstad * Nåværende arbeidssted: Svensedammen Legesenter Drammen.

Insights

Newborn hearing screening using otoacoustic emissions (OAE) effectively identifies congenital hearing loss in neonates. Early diagnosis and treatment initiation before six months improved significantly, aligning with national and international prevalence rates.

Area of Science:

  • Audiology
  • Neonatal Care
  • Public Health

Background:

  • Congenital hearing loss affects 1-3 per 1,000 newborns, necessitating early detection.
  • Otoacoustic emissions (OAE) are recommended for universal newborn hearing screening.
  • Timely intervention before six months of age is crucial for optimal developmental outcomes.

Purpose of the Study:

  • To determine the prevalence of congenital hearing loss in a large Norwegian newborn cohort.
  • To evaluate the effectiveness of otoacoustic emissions (OAE) as a screening tool.
  • To assess changes in the age of diagnosis over a ten-year period.

Main Methods:

  • A decade-long prospective study (2000-2009) screened 29,485 neonates in Østfold county using OAE.
  • Infants with absent emissions were referred for further audiological evaluation.
  • Follow-up data extended to 2013, including cases with initially normal screening but later diagnosed hearing loss.

Main Results:

  • A total of 31 neonates (0.11%) were diagnosed with hearing loss via OAE screening.
  • The median age of diagnosis decreased from 13 to 6 months, with more cases diagnosed before six months.
  • Delayed-onset hearing loss was identified in 10 children (0.03%), with a median diagnosis age of 36 months.

Conclusions:

  • The prevalence of hearing loss in the studied cohort aligns with Norwegian and international data.
  • Otoacoustic emissions (OAE) proved effective for neonatal hearing screening in a hospital setting.
  • The adoption of automated auditory brainstem response audiometry (AABR) reduced the need for invasive testing under anesthesia.
Abstract